DUBLIN--(BUSINESS WIRE)-- Research and Markets (http://www.researchandmarkets.com/research/z2k5lt/colorectal_cancer) has announced the addition of Decision Resources, Inc's new report "Colorectal Cancer (Event Driven)" to their offering.
Colorectal cancer (CRC) is one of the most common forms of cancer and in 2010 was the fifth most common cancer-related death worldwide. Over the next ten years the number of incident cases of CRC will increase as the aging population continues to expand and patients continue to be identified through screening efforts throughout the major markets. Although in 2010 major-market sales of CRC treatments totaled more than $7 billion, reflecting robust sales of premium-priced products, interviewed experts express the demand for more treatments that address CRC patients' numerous unmet needs.
Key Topics Covered:
What are the key parameters of the colorectal cancer market?
What factors are driving the market for colorectal cancer therapies?
What factors are constraining the market for colorectal therapies?
What are the drug development activities of note in colorectal cancer?
What do the experts say?
What key challenges and opportunities remain?
1 Etiology and Pathophysiology
2 Epidemiology and Patient Populations
3 Current Therapy and Medical Practice
4 Unmet Needs
5 Emerging Therapies
6 Market Outlook
Tables and Figures
For more information visit http://www.researchandmarkets.com/research/z2k5lt/colorectal_cancer
Source: Decision Resources, Inc
Source: Research and Markets